Bitter taste receptors are involved in asthma relieved by aspirin: A hypothesis.
文献摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs) typically do not affect asthma symptoms in most people. However, there are unique subgroups of patients whose responses to NSAIDs diverge considerably from the norm. Among these individuals, some experience an exacerbation of their asthma - commonly identified as aspirin- or NSAID-exacerbated respiratory disease (AERD and N-ERD, respectively). In contrast, others exhibit a remarkable improvement in their asthma symptoms following the administration of NSAIDs. This improvement is characterized by rapid, pronounced, and long-lasting bronchodilation, resulting in a substantial improvement in clinical symptoms and enhanced respiratory function. The observation of such contrasting responses has prompted further investigation into the mechanisms that might explain this phenomenon. Our hypothesis centers on the activation of bitter taste receptors by NSAIDs, resulting in rapid, significant, and sustained bronchodilation. Notably, this bronchodilator effect closely mirrors the relief observed in those asthma cases that improve with NSAID use. This mechanism provides a potential biological basis for their distinct response to NSAID therapy.